STOCK TITAN

Sage Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 4:30 p.m. PT in San Francisco, CA.

A live webcast of the presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Investor

Ashley Kaplowitz

786-252-1419

ashley.kaplowitz@sagerx.com



Media Contact

Matthew Henson

917-930-7147

matthew.henson@sagerx.com

Source: Sage Therapeutics, Inc.

FAQ

When will Sage Therapeutics, Inc. present at the 42nd Annual J.P. Morgan Healthcare Conference?

Sage Therapeutics, Inc. will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024, at 4:30 p.m. PT in San Francisco, CA.

Where can the live webcast of the presentation be accessed?

The live webcast of the presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com.

Will there be a replay of the webcast available?

Yes, a replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.
Sage Therapeutic

NASDAQ:SAGE

SAGE Rankings

SAGE Latest News

SAGE Stock Data

454.96M
54.09M
11.94%
79.96%
6.37%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE